
Expert Insights: Reducing Risk in Neurodegenerative Drug Discovery

Research highlights: Targeted Protein Degradation in Tauopathies

Case Study: Development of a human iPSC-derived ALS model
-1.png)
The status of drug discovery and development for Parkinson's disease

ALS Pathology and Drug Targets Using In Vitro iPSC Models
-1.png)
The status of drug discovery and development for Alzheimer's disease
